Probiotics as a Therapeutic Approach in Colorectal Cancer
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
Colorectal cancer (CRC) is a growing concern worldwide. In recent decades, the incidence of CRC has increased, and this has been attributed to changes in lifestyle. The lack of physical activity, smoking habits, and a diet high in red meat and fat and low in fiber are important aspects of these deleterious changes in lifestyle. The increase in the incidence of CRC has impelled researchers to investigate methods for preventing and treating CRC with greater efficacy and fewer complications. Probiotics are an attractive and potentially promising therapeutic approach. They have been evaluated by a large number of preclinical and clinical studies in recent years, and it has been found that they can play a role in the prevention, treatment, and management of complications of CRC. This review provides a concise summary of the mechanisms of action of probiotics. Furthermore, it focuses on the results of clinical and preclinical studies that evaluated probiotics' effects on CRC management. It also discusses the effects of different strains of probiotics and their combination in CRC treatment.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
---|---|
Enthalten in: |
Current cancer drug targets - 23(2023), 10 vom: 13., Seite 764-777 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rahmani, Nafiseh [VerfasserIn] |
---|
Links: |
---|
Themen: |
CRC management |
---|
Anmerkungen: |
Date Completed 29.08.2023 Date Revised 02.09.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.2174/1568009623666230413081513 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM355736543 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM355736543 | ||
003 | DE-627 | ||
005 | 20231226064956.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/1568009623666230413081513 |2 doi | |
028 | 5 | 2 | |a pubmed24n1185.xml |
035 | |a (DE-627)NLM355736543 | ||
035 | |a (NLM)37069719 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rahmani, Nafiseh |e verfasserin |4 aut | |
245 | 1 | 0 | |a Probiotics as a Therapeutic Approach in Colorectal Cancer |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.08.2023 | ||
500 | |a Date Revised 02.09.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a Colorectal cancer (CRC) is a growing concern worldwide. In recent decades, the incidence of CRC has increased, and this has been attributed to changes in lifestyle. The lack of physical activity, smoking habits, and a diet high in red meat and fat and low in fiber are important aspects of these deleterious changes in lifestyle. The increase in the incidence of CRC has impelled researchers to investigate methods for preventing and treating CRC with greater efficacy and fewer complications. Probiotics are an attractive and potentially promising therapeutic approach. They have been evaluated by a large number of preclinical and clinical studies in recent years, and it has been found that they can play a role in the prevention, treatment, and management of complications of CRC. This review provides a concise summary of the mechanisms of action of probiotics. Furthermore, it focuses on the results of clinical and preclinical studies that evaluated probiotics' effects on CRC management. It also discusses the effects of different strains of probiotics and their combination in CRC treatment | ||
650 | 4 | |a Review | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a CRC management | |
650 | 4 | |a Colorectal cancer | |
650 | 4 | |a complications | |
650 | 4 | |a prevention | |
650 | 4 | |a probiotics | |
650 | 4 | |a treatment | |
700 | 1 | |a Pourali, Ghazaleh |e verfasserin |4 aut | |
700 | 1 | |a Hosseini, Nayyerehalsadat |e verfasserin |4 aut | |
700 | 1 | |a Fiuji, Hamid |e verfasserin |4 aut | |
700 | 1 | |a Maftooh, Mina |e verfasserin |4 aut | |
700 | 1 | |a Hassanian, Seyed Mahdi |e verfasserin |4 aut | |
700 | 1 | |a Ferns, Gordon A |e verfasserin |4 aut | |
700 | 1 | |a Khazaei, Majid |e verfasserin |4 aut | |
700 | 1 | |a Avan, Amir |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current cancer drug targets |d 2001 |g 23(2023), 10 vom: 13., Seite 764-777 |w (DE-627)NLM120490560 |x 1873-5576 |7 nnns |
773 | 1 | 8 | |g volume:23 |g year:2023 |g number:10 |g day:13 |g pages:764-777 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/1568009623666230413081513 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 23 |j 2023 |e 10 |b 13 |h 764-777 |